Interestingly, tumor cells primed by LysM-Atg5-/- BMDMs had a superior ability to induce the M2 markers CD206 and CD11b on wild-type BMDMs compared to tumor cells primed by Atg5flox/flox BMDM. The gene discussed is ATG5; the disease is neoplasm.